Entering text into the input field will update the search result below

Aurinia stock rises as Q4 loss narrows, Lupkynis revenue grows; reaffirms product outlook

Feb. 28, 2023 11:15 AM ETAurinia Pharmaceuticals Inc. (AUPH) StockBy: Ravikash Bakolia, SA News Editor2 Comments

Businessman draws increase arrow graph corporate future growth year 2021 to 2022. Development to success and motivation.

Galeanu Mihai

Aurinia Pharmaceuticals (NASDAQ:AUPH) stock rose ~8% on Tuesday after Q4 net loss narrowed and revenue grew Y/Y.

Net loss was -$26.05M, compared to -$33.32M in Q4 2021.

Total net revenue grew +21.5% Y/Y to ~$28.44M, however it missed analysts estimates.

Recommended For You

About AUPH Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
AUPH--
Aurinia Pharmaceuticals Inc.